Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Scientific Reports|February 15, 2023
A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancerMarie Grosgeorges, Laurence Picque Lasorsa, Brice Pastor, et al.Scientific Reports|January 27, 2021
Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cellsMaëva Chauvin, Véronique Garambois, Pierre-Emmanuel Colombo, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2025
MHC-I-Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical TherapyJulie Constanzo, Aliasghar Parach, Timothee David, et al.Antioxidants & Redox Signaling|May 26, 2016
Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted EffectsSalomé Paillas, Riad Ladjohounlou, Catherine Lozza, et al.British Journal of Pharmacology|November 29, 2023
Anti-cathepsin D immunotherapy triggers both innate and adaptive anti-tumour immunity in breast cancerTimothée David, Aude Mallavialle, Julien Faget, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2016
Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and MetastasisWilhem Leconet, Myriam Chentouf, Stanislas du Manoir, et al.Mabs|January 4, 2019
A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functionsMadeline Neiveyans, Rana Melhem, Christophe Arnoult, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2023
Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide TherapyClara Diaz Garcia-Prada, Léna Carmes, Salima Atis, et al.International Journal of Cancer|March 19, 2019
An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancerLaura Bourillon, Céline Bourgier, Nadège Gaborit, et al.Oncotarget|December 10, 2017
Checkpoint kinase 1 inhibition sensitises transformed cells to dihydroorotate dehydrogenase inhibitionStéphanie Arnould, Geneviève Rodier, Gisèle Matar, et al.Pageof 7